Patients younger than forty years old with hepatitis C virus genotype–1 chronic infection had treatment responses similar to genotype–2 infection and not related to interleukin–28B polymorphism

Background and rationale. Age is one of the predictors for sustained virological response (SVR) when treating chronic hepatitis C (CHC) patients with pegylated-interferon/ribavirin (PegIFN/RBV). However, the treatment responses of the young patients had not been analyzed before. Therefore, we conduc...

Full description

Bibliographic Details
Main Authors: Chun-Yen Lin, M.D. Ph.D., I-Shyan Sheen, Wen-Juei Jeng, Chang-Wen Huang, Chien-Hao Huang, Ji-Yih Chen
Format: Article
Language:English
Published: Elsevier 2013-01-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119313869

Similar Items